NHS to Boost Urgent Care with £140m Funding Amid Winter Pressure

The National Health Service (NHS) is bracing for a more challenging winter than usual, with increased pressure on the healthcare system expected. Yvette Cooper, the health secretary, has warned of the potential for increased demand on the system, citing the impact of seasonal illnesses such as flu and norovirus.

To address this, the government has announced a £140m funding package to support urgent care capacity.

Read More: MP Allison Gardner Demands UK Action on Chronic UTIs

The funding will be allocated to 14 schemes across England. This includes the development of new urgent care centres, upgrades to ambulance fleets, and enhancements to emergency departments. Damian Hinds, the shadow health secretary, has called on the government to explain the source of the funding.

Meanwhile, the Royal College of Nursing (RCN) England has expressed concerns that the funding is insufficient to address the underlying issues facing the NHS.

The NHS is facing a "twin crisis" as the summer heatwave comes to an end, with the service struggling to recover from the peak period of demand. The King's Fund, a health thinktank, has warned that the NHS is ill-equipped to handle the increased pressure, with little time between peak periods for staff to rest and recover.

Medical director Prof Frankie Swords has urged eligible individuals to seek flu vaccinations, citing "ominous" signs of winter pressure already affecting hospitals. She also highlighted the need for patients to wait for treatment in a timely manner. Emphasizing the importance of timely care for those in need.

Also Read: Hospital Doctors in Northern Ireland Announce Strikes Amid Pay Dispute

The waiting list for routine hospital treatment in England has continued to rise. With the latest data showing an estimated 7.37 million treatments waiting to be carried out at the end of August. This represents the highest number since October 2025.

And raises concerns about the NHS's ability to meet its target of treating 92% of patients within 18 weeks by 2029.